Saint Alphonsus Medical Group
Boise, Idaho, 83706, United States
NCT Number: NCT02912351
This is a retrospective, single-site observational study, designed to assess the clinical outcomes and collect safety data of GMK Revision knee system used for primary or revision total knee arthroplasty at minimum two years post-treatment.
Looking for future studies?
Notify MeAll sexes
Observational
Boise, Idaho, 83706, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
KSS-Objective Knee Scores, KSS Subsets, Radiographs and Patient Satisfaction
Time frame: Minimum 2 years post surgery
Total Knee Society Score questionnaire to assess Patient satisfaction and Patient expectations and objective knee scores.
Time frame: Minimum 2 years post surgery
Radiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration and the presence and progression of radiolucent line between the prosthesis, bone and cement.
Time frame: Minimum 2 years post surgery
Assessed with a Likert scale questionnaire for satisfaction of treatment outcome.
Time frame: minimum 2 years post surgery
by reviewing Adverse Events
Medacta USA
Industry
A Post-Market, Single-Center, Retrospective Study to Collect Clinical Outcomes and Safety Data From Patients Who Have Undergone Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis and Are at Least 2 Years Past Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108496
Arthritis, Joint Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT07720024
Arthritis, Blount disease
Pathum Thani, Changwat Pathum Thani, Thailand
View Trial DetailsNCT01818401
Arthritis, Joint Diseases
Nantes, France
View Trial DetailsNCT07710404
Arthritis, Joint Diseases
Faisalābad, Punjab Province, Pakistan
View Trial Details